News & Events

Home News & Events

16

Sep2024

*NEW* Report Release: “Issues and Opportunities to Modernize Private Drug Plan Sustainability in an Evolving Market”

/ Private Payers, Publications, What's New
PDCI Market Access, a Division of McKesson Canada Corporation has released a whitepaper investigating the design and sustainability of private drug benefits in Canada. The report, commissioned by Innovative Medicines Canada, uncovers critical gaps in private insurance risk pooling that leave many small plan sponsors with tough decisions ... Read More

21

Aug2024

Connect with PDCI Market Access at CDA Symposium 2024

/ What's New
PDCI Market Access, a division of McKesson Canada, is a Platinum Sponsor of CDA's Symposium 2024 taking place in Ottawa on September 4-6, 2024. PDCI’s Kaitlyn Proulx, Andrea Lau, Ara Salazar, Tuhin Maity, Sam Ali and Hussein El-Khechen, along with our McKesson colleagues ... Read More

28

Jun2024

PMPRB Releases Long Awaited Discussion Guide as Phase 2 of the New Guidelines Consultation Process

/ PMPRB, What's New
On Wednesday, June 26th, PMPRB initiated Phase 2 of the consultation process by publishing the Discussion Guide that will help shape future guidelines. They have indicated that changes to the Guidelines are necessary to address their new legislative and jurisprudential reality and are committed to modernizing and simplifying ... Read More

31

Jan2024

CADTH Update Introduces Streamlined Economic Reports and Launches BIA Template Consultation

/ CADTH, What's New
On Friday, CADTH’s Pharmaceutical Reviews Update – Issue 43 introduced a number of updates pertaining to its Reimbursement Reviews procedures. These include: Budget Impact Analysis (BIA) Consultation: CADTH is seeking stakeholder feedback on its draft BIA template tool. The tool is an optional resource to ... Read More

20

Dec2023

New Issue of INSIGHTS Released

/ PDCI, What's New
PDCI released a new issue of PDCI Market Access INSIGHTS, featuring research and opinion on the evolving state of private health insurance in Canada. In this Issue:... Read More

19

Dec2023

Happy Holidays from PDCI!

/ PDCI, What's New
As another memorable year draws to a close, the team at PDCI Market Access would like to express its sincere gratitude and appreciation for all our clients, partners, and people who support us in our purpose to improve health outcomes for all.We hope your holiday season is filled ... Read More

14

Nov2023

PMPRB Provides Themes For First Step Of Guidelines Consultation; Announces Appointments Of Two New Board Members

/ News, PMPRB
First Step of The New Guidelines Consultation Announced On October 25, 2023, the Patented Medicine Prices Review Board (PMPRB) released details on the first  of its two-step consultation process for developing its new set of price regulatory guidelines. PMPRB will send invitations to stakeholders for ... Read More

13

Nov2023

PMPRB Invites Stakeholder Feedback on Scoping Paper on Themes for New Guidelines

/ News, PMPRB
On November 10, 2023, the Patented Medicine Prices Review Board (PMPRB) launched first phase of its consultation process towards development of new price regulatory Guidelines. PMPRB published its Scoping Paper for the Consultations on the Board’s Guidelines and invited feedback to be provided either ... Read More

02

Oct2023

PMPRB Publishes Final Decision on Amended Interim Guidance

/ News, PMPRB, What's New
On September 27, 2023, the Patented Medicine Prices Review Board (PMPRB) published its final decision regarding the Amended Interim Guidance first proposed on June 20, 2023.Effective immediately, the proposed amendments to the Interim Guidance are implemented without changes, notwithstanding the concerns raised by many of the ... Read More

08

Sep2023

PDCI Strengthens Leadership to Enhance Real World Evidence (RWE) Services and Strategic Consulting Capabilities

/ News, PDCI
Mississauga, ON - September 11, 2023 – Canada’s leading biopharmaceutical pricing and reimbursement consultancy, PDCI Market Access (PDCI), a division of McKesson Canada, today announced the appointment of three leaders, Nabil Tadros, Andrea Lau and John-Paul Dowson to further enhance the company’s capabilities in delivering high-quality services and ... Read More